Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Prognostic Impact of Combined Progression Index Based on Peritoneal Grading Regression Score and Peritoneal Cytology in Peritoneal Metastasis.

Benzerdjeb N, Durieux E, Tantot J, Isaac S, Fontaine J, Harou O, Glehen O, Kepenekian V, Alyami M, Villeneuve L, Laplace N, Traverse-Glehen A, Shisheboran-Devouassoux M, Bakrin N.

Histopathology. 2020 Feb 14. doi: 10.1111/his.14092. [Epub ahead of print]

PMID:
32060943
2.

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Lévesque E, Labriet A, Hovington H, Allain ÉP, Melo-Garcia L, Rouleau M, Brisson H, Turcotte V, Caron P, Villeneuve L, Leclercq M, Droit A, Audet-Walsh E, Simonyan D, Fradet Y, Lacombe L, Guillemette C.

Br J Cancer. 2020 Feb 12. doi: 10.1038/s41416-020-0749-2. [Epub ahead of print]

PMID:
32047296
3.

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.

You B, Mercier F, Assenat E, Langlois-Jacques C, Glehen O, Soulé J, Payen L, Kepenekian V, Dupuy M, Belouin F, Morency E, Saywell V, Flacelière M, Elies P, Liaud P, Mazard T, Maucort-Boulch D, Tan W, Vire B, Villeneuve L, Ychou M, Kohli M, Joubert D, Prieur A.

EBioMedicine. 2020 Jan;51:102574. doi: 10.1016/j.ebiom.2019.11.035. Epub 2019 Dec 24.

4.

Wash your hands, Brother John!

Thampi N, Villeneuve LN, Longtin Y.

BMJ. 2019 Dec 16;367:l6050. doi: 10.1136/bmj.l6050. No abstract available.

PMID:
31843809
5.

Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.

Vaillancourt J, Turcotte V, Caron P, Villeneuve L, Lacombe L, Pouliot F, Lévesque É, Guillemette C.

Drug Metab Dispos. 2020 Feb;48(2):75-84. doi: 10.1124/dmd.119.088229. Epub 2019 Nov 14.

PMID:
31727674
6.

The value of BRCA-1-associated protein 1 expression and cyclin-dependent kinase inhibitor 2A deletion to distinguish peritoneal malignant mesothelioma from peritoneal location of carcinoma in effusion cytology specimens.

Althakfi W, Gazzo S, Blanchet M, Isaac S, Piaton E, Villeneuve L, Glehen O, Gilly FN, Brevet M.

Cytopathology. 2020 Jan;31(1):5-11. doi: 10.1111/cyt.12788.

PMID:
31713897
7.

Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.

Labriet A, Lévesque É, De Mattia E, Cecchin E, Jonker D, Couture F, Simonyan D, Buonadonna A, D'Andrea M, Villeneuve L, Toffoli G, Guillemette C.

Pharmacogenomics. 2019 Nov;20(17):1179-1187. doi: 10.2217/pgs-2019-0091. Epub 2019 Nov 8.

PMID:
31698983
8.

Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.

Labriet A, Lévesque É, Cecchin E, De Mattia E, Villeneuve L, Rouleau M, Jonker D, Couture F, Simonyan D, Allain EP, Buonadonna A, D'Andrea M, Toffoli G, Guillemette C.

Sci Rep. 2019 Sep 10;9(1):13008. doi: 10.1038/s41598-019-49477-3.

9.

Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia.

Allain EP, Rouleau M, Le T, Vanura K, Villeneuve L, Caron P, Turcotte V, Lévesque E, Guillemette C.

Front Oncol. 2019 Jul 4;9:606. doi: 10.3389/fonc.2019.00606. eCollection 2019.

10.

Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications.

Alyami M, Hübner M, Grass F, Bakrin N, Villeneuve L, Laplace N, Passot G, Glehen O, Kepenekian V.

Lancet Oncol. 2019 Jul;20(7):e368-e377. doi: 10.1016/S1470-2045(19)30318-3. Review.

PMID:
31267971
11.

Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Alyami M, Mercier F, Siebert M, Bonnot PE, Laplace N, Villeneuve L, Passot G, Glehen O, Bakrin N, Kepenekian V.

Eur J Surg Oncol. 2019 Jun 21. pii: S0748-7983(19)30522-0. doi: 10.1016/j.ejso.2019.06.028. [Epub ahead of print] Review.

PMID:
31253545
12.

Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice.

Caland L, Labbé P, Mamarbachi M, Villeneuve L, Ferbeyre G, Noly PE, Carrier M, Thorin-Trescases N, Thorin É.

Aging (Albany NY). 2019 Jun 11;11(11):3832-3850. doi: 10.18632/aging.102020.

13.

p38α MAPK inhibition translates to cell cycle re-entry of neonatal rat ventricular cardiomyocytes and de novo nestin expression in response to thrombin and after apex resection.

Hertig V, Brezai A, Bergeron A, Villeneuve L, Gillis MA, Calderone A.

Sci Rep. 2019 Jun 3;9(1):8203. doi: 10.1038/s41598-019-44712-3.

14.

Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice.

Pinçon A, De Montgolfier O, Akkoyunlu N, Daneault C, Pouliot P, Villeneuve L, Lesage F, Levy BI, Thorin-Trescases N, Thorin É, Ruiz M.

Metabolites. 2019 May 25;9(5). pii: E104. doi: 10.3390/metabo9050104.

15.

Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain Development.

Stauch KL, Villeneuve LM, Totusek S, Lamberty B, Ciborowski P, Fox HS.

Dev Neurobiol. 2019 Apr;79(4):370-386. doi: 10.1002/dneu.22684. Epub 2019 May 9.

PMID:
31050203
16.

Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report.

Palejwala AH, O'Connor KP, Shi H, Villeneuve L, Scordino T, Glenn CA.

J Clin Neurosci. 2019 Jun;64:269-276. doi: 10.1016/j.jocn.2019.04.011. Epub 2019 Apr 24. Review.

PMID:
31029526
17.

Resection of Pediatric Trigeminal Schwannoma Using Minimally Invasive Approach: Case Report, Literature Review, and Operative Video.

O'Connor KP, Pelargos PE, Palejwala AH, Shi H, Villeneuve L, Glenn CA.

World Neurosurg. 2019 Jul;127:518-524. doi: 10.1016/j.wneu.2019.04.113. Epub 2019 Apr 19. Review.

PMID:
31009782
18.

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma.

Lurvink RJ, Villeneuve L, Govaerts K, de Hingh IHJT, Moran BJ, Deraco M, Van der Speeten K, Glehen O, Kepenekian V, Kusamura S; List of PSOGI collaborators.

Eur J Surg Oncol. 2019 Mar 23. pii: S0748-7983(19)30337-3. doi: 10.1016/j.ejso.2019.03.012. [Epub ahead of print] Review.

PMID:
30954350
19.

Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study.

Le Stang N, Bouvier V, Glehen O, Villeneuve L; FRANCIM network; MESOPATH Referent National Center, Galateau-Sallé F, Clin B.

Cancer Epidemiol. 2019 Jun;60:106-111. doi: 10.1016/j.canep.2019.03.014. Epub 2019 Apr 3.

PMID:
30953970
20.

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative study.

Siebert M, Alyami M, Mercier F, Gallice C, Villeneuve L, Laplace N, Passot G, Bakrin N, Glehen O, Kepenekian V.

Eur J Surg Oncol. 2019 Mar 20. pii: S0748-7983(19)30349-X. doi: 10.1016/j.ejso.2019.03.021. [Epub ahead of print]

PMID:
30914289
21.

O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET).

Lemelin A, Barritault M, Hervieu V, Payen L, Péron J, Couvelard A, Cros J, Scoazec JY, Bin S, Villeneuve L, Lombard-Bohas C, Walter T; MGMT-NET investigators.

Dig Liver Dis. 2019 Apr;51(4):595-599. doi: 10.1016/j.dld.2019.02.001. Epub 2019 Feb 14.

PMID:
30824408
22.

Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.

Émond JP, Labriet A, Desjardins S, Rouleau M, Villeneuve L, Hovington H, Brisson H, Lacombe L, Simonyan D, Caron P, Périgny M, Têtu B, Fallon JK, Klein K, Smith PC, Zanger UM, Guillemette C, Lévesque E.

Drug Metab Dispos. 2019 May;47(5):444-452. doi: 10.1124/dmd.119.086330. Epub 2019 Feb 28.

PMID:
30819787
23.

A multimodal and multidisciplinary program to prevent loss of mobility in patients aged over 70 years: study protocol of a multicenter cluster randomized study in primary care (the PRISME-3P study).

Perrotin S, Gilbert T, Dupuis M, Villeneuve L, Bin-Dorel S, Klich A, Letrilliart L, Bonnefoy M.

BMC Geriatr. 2019 Feb 19;19(1):48. doi: 10.1186/s12877-019-1059-5.

24.

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry.

Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemartin C, Lherm Y, Villeneuve L, Kepenekian V, Marchal F; RENAPE Network.

Ann Surg Oncol. 2019 Mar;26(3):852-860. doi: 10.1245/s10434-018-07153-2. Epub 2019 Jan 11.

PMID:
30635798
25.

High Systolic Blood Pressure Induces Cerebral Microvascular Endothelial Dysfunction, Neurovascular Unit Damage, and Cognitive Decline in Mice.

de Montgolfier O, Pinçon A, Pouliot P, Gillis MA, Bishop J, Sled JG, Villeneuve L, Ferland G, Lévy BI, Lesage F, Thorin-Trescases N, Thorin É.

Hypertension. 2019 Jan;73(1):217-228. doi: 10.1161/HYPERTENSIONAHA.118.12048.

PMID:
30571552
26.

Increased incidence of Campylobacter enteritis and their quinolone resistance between 2010 and 2015: Results of a French national observatory conducted in 21 general hospitals (CHG).

Trompette M, Le Guilloux L, Souply L, Denis B, Tsouria A, Garrec H, Quentin V, Vaucel J, Locher C, Barjonet G, Marthelet P, Causse X, Poisson D, Nahon S, Joubrel-Guyot C, Grasset D, Pouedras P, Renou C, Toyer AL, Boruchowicz A, Cattoen C, Heluwaert F, Bland S, Faroux R, Desroys V, Paupard T, Verhaeghe A, Correro MO, Pujol C, Picon M, Gallou J, Kaassi M, Touroult-Jupin P, Arotcarena R, Villeneuve L, Payen JL, Libier L, Charpignon C, Rahma M, Manuardi AG, Jeanne A, Lahmek P, Condat B, Macaigne G.

Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):338-345. doi: 10.1016/j.clinre.2018.10.015. Epub 2018 Dec 7.

PMID:
30528512
27.

No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.

Larbre V, Alyami M, Mercier F, Vantard N, Bonnefoy I, Opsomer MA, Villeneuve L, Bakrin N, Rioufol C, Glehen O, Kepenekian V.

Anticancer Res. 2018 Dec;38(12):6869-6875. doi: 10.21873/anticanres.13062.

PMID:
30504403
28.

Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.

Siebert M, Alyami M, Mercier F, Gallice C, Villeneuve L, Bérard F, Glehen O, Bakrin N, Kepenekian V.

Cancer Chemother Pharmacol. 2019 Mar;83(3):425-430. doi: 10.1007/s00280-018-3740-3. Epub 2018 Dec 3.

PMID:
30511218
29.

Proteomic and functional data sets on synaptic mitochondria from rats with genetic ablation of Parkin.

Villeneuve LM, Stauch KL, Purnell PS, Fox HS.

Data Brief. 2018 Aug 28;20:568-572. doi: 10.1016/j.dib.2018.08.053. eCollection 2018 Oct.

30.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups.

Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.

PMID:
30131104
31.

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.

Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D, Sugarbaker PH, Baratti D, Quenet F, Bartlett DL, Villeneuve L, Kepenekian V; PSOGI and BIG-RENAPE Working Groups.

Eur J Surg Oncol. 2018 Nov;44(11):1786-1792. doi: 10.1016/j.ejso.2018.05.021. Epub 2018 May 28.

PMID:
29885982
32.

Adding methylphenidate to prism-adaptation improves outcome in neglect patients. A randomized clinical trial.

Luauté J, Villeneuve L, Roux A, Nash S, Bar JY, Chabanat E, Cotton F, Ciancia S, Sancho PO, Hovantruc P, Quelard F, Sarraf T, Cojan Y, Hadj-Bouziane F, Farné A, Janoly-Dumenil A, Boisson D, Jacquin-Courtois S, Rode G, Rossetti Y.

Cortex. 2018 Sep;106:288-298. doi: 10.1016/j.cortex.2018.03.028. Epub 2018 Apr 4.

PMID:
29703446
33.

Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.

Mercier F, Bakrin N, Bartlett DL, Goere D, Quenet F, Dumont F, Heyd B, Abboud K, Marolho C, Villeneuve L, Glehen O; PSOGI Working Group; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Jun;25(6):1668-1675. doi: 10.1245/s10434-018-6464-z. Epub 2018 Apr 10.

PMID:
29637438
34.

Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.

Audet-Delage Y, Villeneuve L, Grégoire J, Plante M, Guillemette C.

Front Endocrinol (Lausanne). 2018 Mar 12;9:87. doi: 10.3389/fendo.2018.00087. eCollection 2018.

35.

Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).

Passot G, Dumont F, Goéré D, Arvieux C, Rousset P, Regimbeau JM, Elias D, Villeneuve L, Glehen O; BIG-RENAPE Surgery Working Group.

Br J Surg. 2018 May;105(6):663-667. doi: 10.1002/bjs.10723. Epub 2018 Mar 26.

PMID:
29579322
36.

Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.

Vigneault P, Naud P, Qi X, Xiao J, Villeneuve L, Davis DR, Nattel S.

J Physiol. 2018 Jun;596(12):2359-2379. doi: 10.1113/JP275388. Epub 2018 May 5.

37.

Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.

Nowacki M, Alyami M, Villeneuve L, Mercier F, Hubner M, Willaert W, Ceelen W, Reymond M, Pezet D, Arvieux C, Khomyakov V, Lay L, Gianni S, Zegarski W, Bakrin N, Glehen O.

Eur J Surg Oncol. 2018 Jul;44(7):991-996. doi: 10.1016/j.ejso.2018.02.014. Epub 2018 Feb 22.

PMID:
29526367
38.

Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Labriet A, Allain EP, Rouleau M, Audet-Delage Y, Villeneuve L, Guillemette C.

Drug Metab Dispos. 2018 May;46(5):514-524. doi: 10.1124/dmd.117.079921. Epub 2018 Feb 9.

39.

Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.

Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Apr;25(4):1094-1100. doi: 10.1245/s10434-017-6299-z. Epub 2017 Dec 13.

PMID:
29238881
40.

Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.

Audet-Delage Y, Grégoire J, Caron P, Turcotte V, Plante M, Ayotte P, Simonyan D, Villeneuve L, Guillemette C.

J Steroid Biochem Mol Biol. 2018 Apr;178:45-54. doi: 10.1016/j.jsbmb.2017.10.021. Epub 2017 Oct 29.

PMID:
29092787
41.

Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.

Labriet A, De Mattia E, Cecchin E, Lévesque É, Jonker D, Couture F, Buonadonna A, D'Andrea M, Villeneuve L, Toffoli G, Guillemette C.

Front Pharmacol. 2017 Oct 10;8:712. doi: 10.3389/fphar.2017.00712. eCollection 2017.

42.

Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation.

Gélinas R, El Khoury N, Chaix MA, Beauchamp C, Alikashani A, Ethier N, Boucher G, Villeneuve L, Robb L, Latour F, Mondesert B, Rivard L, Goyette P, Talajic M, Fiset C, Rioux JD.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001755. doi: 10.1161/CIRCGENETICS.117.001755.

PMID:
29021306
43.

Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.

Alyami M, Gagniere J, Sgarbura O, Cabelguenne D, Villeneuve L, Pezet D, Quenet F, Glehen O, Bakrin N, Passot G.

Eur J Surg Oncol. 2017 Nov;43(11):2178-2183. doi: 10.1016/j.ejso.2017.09.010. Epub 2017 Sep 21.

PMID:
28964609
44.

Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G.

Int J Hyperthermia. 2018 Aug;34(5):532-537. doi: 10.1080/02656736.2017.1367846. Epub 2017 Aug 24.

PMID:
28838265
45.

Nestin expression is dynamically regulated in cardiomyocytes during embryogenesis.

Hertig V, Matos-Nieves A, Garg V, Villeneuve L, Mamarbachi M, Caland L, Calderone A.

J Cell Physiol. 2018 Apr;233(4):3218-3229. doi: 10.1002/jcp.26165. Epub 2017 Sep 27.

46.

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.

Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M'Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network.

Eur J Surg Oncol. 2017 Oct;43(10):1915-1923. doi: 10.1016/j.ejso.2017.05.009. Epub 2017 May 18.

PMID:
28619621
47.

Nestin expression is upregulated in the fibrotic rat heart and is localized in collagen-expressing mesenchymal cells and interstitial CD31(+)- cells.

Hertig V, Tardif K, Meus MA, Duquette N, Villeneuve L, Toussaint F, Ledoux J, Calderone A.

PLoS One. 2017 Apr 27;12(4):e0176147. doi: 10.1371/journal.pone.0176147. eCollection 2017.

48.

Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues.

Tourancheau A, Rouleau M, Guauque-Olarte S, Villeneuve L, Gilbert I, Droit A, Guillemette C.

Pharmacogenomics J. 2018 Apr;18(2):251-261. doi: 10.1038/tpj.2017.5. Epub 2017 Apr 25.

49.

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.

Villeneuve L, Passot G, Glehen O, Isaac S, Bibeau F, Rousset P, Gilly FN; RENAPE Network.

Orphanet J Rare Dis. 2017 Feb 17;12(1):37. doi: 10.1186/s13023-017-0571-y.

50.

Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo.

Maafi F, Li B, Gebhard C, Brodeur MR, Nachar W, Villeneuve L, Lesage F, Rhainds D, Rhéaume E, Tardif JC.

Atherosclerosis. 2017 Mar;258:8-19. doi: 10.1016/j.atherosclerosis.2017.01.026. Epub 2017 Jan 21.

PMID:
28167355

Supplemental Content

Loading ...
Support Center